Long-term fatty liver-induced insulin resistance in orotic acid-induced nonalcoholic fatty liver rats

Bioscience, Biotechnology and Biochemistry

Volumn 80, Issue 4, 2016, Pages 735-743

  Han, Xiuqing ^a   Liu, Chunhua ^b   Xue, Yong ^a   Wang, Jingfeng ^a   Xue, Changhu ^a   Yanagita, Teruyoshi ^c   Gao, Xiang ^a,d   Wang, Yuming ^a  

^a OCEAN UNIVERSITY OF CHINA   (China)

^b SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY   (China)

^c NISHIKYUSHU UNIVERSITY   (Japan)

^d MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

Fatty liver; Glucose intolerance; Insulin signaling; Lipids

Indexed keywords

ACID RESISTANCE; CARBOXYLIC ACIDS; GENE EXPRESSION; GENES; GLUCOSE; INSULIN; LIPIDS; NUTRITION; RATS;

FATTY LIVER; GENES EXPRESSION; GLUCOSE INTOLERANCE; HEPATIC INSULIN RESISTANCE; INSULIN RESISTANCE; INSULIN SIGNALING; NON-ALCOHOLIC FATTY LIVER; NON-ALCOHOLIC FATTY LIVER DISEASE;

FATTY ACIDS;

INSULIN; OROTIC ACID;

ANIMAL; BLOOD; CHEMICALLY INDUCED; GENE EXPRESSION; GLUCONEOGENESIS; GLUCOSE TOLERANCE TEST; INSULIN RESISTANCE; MALE; NONALCOHOLIC FATTY LIVER; PATHOPHYSIOLOGY; RAT; SIGNAL TRANSDUCTION; UPREGULATION; WISTAR RAT;

ANIMALS; GENE EXPRESSION; GLUCONEOGENESIS; GLUCOSE TOLERANCE TEST; INSULIN; INSULIN RESISTANCE; MALE; NON-ALCOHOLIC FATTY LIVER DISEASE; OROTIC ACID; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 84962425030     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1080/09168451.2015.1123608     Document Type: Article

References (36)

1. Schaffner F, Thaler H. Nonalcoholic fatty liver disease. Prog. Liver Dis. 1986;8:283-298.
2. Kotronen A, Yki-Järvinen H. Fatty Liver: A novel component of the metabolic syndrome. Arterioscler. Thromb. Vasc. Biol. 2007;28:27-38.
3. Bedogni G, Miglioli L, Masutti F, et al. Prevalence of and risk factors for nonalcoholic fatty liver disease: The dionysos nutrition and liver study. Hepatology. 2005;42:44-52.
4. Cohen JC, Horton JD, Hobbs HH. Human fatty liver disease: old questions and new insights. Science. 2011;332:1519-1523.
5. Faidon M, Xiong S, David B, et al. Intrahepatic diacylglycerol content is associated with hepatic insulin resistance in obese subjects. Gastroenterology. 2012;142:1444-1446.
6. Naoki K, Derek ME, Dongyan Z. Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease. Proc. Natl. Acad. Sci. USA. 2011;108:16381-16385.
7. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J. Allergy Clin. Immunol. 2005;115:911-919.
8. Boden G. Free fatty acids-the link between obesity and insulin resistance. Endocr. Pract. 2001;7:44-51.
9. Nishii N, Maeda H, Murahata Y, et al. Experimental hyperlipemia induces insulin resistance in cats. J. Vet. Med. Sci. 2012;74:267-269.
10. Després Jean-Pierre, Lemieux Isabelle. Abdominal obesity and metabolic syndrome. Nature. 2006;444:881-887.
11. Chen W, Yu M, Zhu M, et al. Clinical analysis on metabolic syndrome in the elderly cadres. J. Shanghai Med. 2004;31: 199-201.
12. Wilson PW, D'Agostino RB, Parise H, et al. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation. 2005;112:3066-3072.
13. Elena VK, Natalia ET, Alla VR. Gender differences in lipid metabolism of the young patients with metabolic syndrome longtime living in the North. Life Sci J. 2014;11:270-274.
14. Mohamed A, François RJ. Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link? Mol. Cell. Endocrinol. 2015;S0303-7207:00094-00095.
15. Standerfer SB, Handler P. Fatty liver induced by orotic acid feeding. Exp. Biol. Med. 1955;90:270-271.
16. Zhang B, Xue C, Hu X, et al. Dietary sea cucumber cerebroside alleviates orotic acid-induced excess hepatic adipopexisin rats. Lipids Health Dis. 2012;8:11-48.
17. Cha JY, Mameda Y, Yamamoto K, et al. Association between hepatic triacylglycerol accumulation induced by administering orotic acid and enhanced phosphatidate phosphohydrolase activity in rats. Biosci. Biotechnol. Biochem. 1998;62:508-513.
18. Wang Y, Hu X, Xue Y, et al. Study on possible mechanism of orotic acid-induced fatty liver in rats. Nutrition. 2011;27:571-575.
19. Ken-ichiro K, Yumie T, Hirofumi M, et al. Liver steatosis is associated with insulin resistance in skeletal muscle rather than in the liver in Japanese patients with non-alcoholic fatty liver disease. J. Diabetes Investig. 2015;6:158-163.
20. Asai A, Chou PM, Bu HF, et al. Dissociation of hepatic insulin resistance from susceptibility of nonalcoholic fatty liver disease induced by a high-fat and high-carbohydrate diet in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 2014;306:G496-G504.
21. Samuel VT1, Liu ZX, Qu. X, et al. Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease. J. Biol. Chem. 2004;279:32345-32353.
22. Padiya R, Khatua TN, Bagul PK, et al. Banerjee garlic improves insulin sensitivity and associated metabolic syndromes in fructose fed rats nutrition and metabolism. Nutr. Metab. (Lond). 2011;27:8-53.
23. Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation purification of total lipids from animal tissues. J. Biol. Chem. 1957;226:497-509.
24. Bartlett GR. Phosphorous assay in column chromatography. J. Biol. Chem. 1959;234:466-468.
25. Cohen P. Control of Enzyme Activity. New York, NY: Chapman and Hall; 1983.
26. Cohen P, Frame S. The renaissance of GSK3. Nat. Rev. Mol. Cell Biol. 2001;2:769-776.
27. Angulo P. Nonalcoholic fatty liver disease. N. Engl. J. Med. 2002;346:1221-1231.
28. Fabbrini E, Sullivan S, Klein S. Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology. 2010;51:679-689.
29. Shulman GI. Cellular mechanisms of insulin resistance. J. Clin. Invest. 2000;106:171-176.
30. Srivastava AK, Pandey SK. Potential mechanism(s) involved in the regulation of glycogen synthesis by insulin. Mol. Cell. Biochem. 1998;182:135-141.
31. Lochhead PA, Salt IP, Walker KS, et al. 5-aminoimidazole-4-carboxamide riboside mimics the effects of insulin on the expression of the 2 key gluconeogenic genes PEPCK and glucose-6-phosphatase. Diabetes. 2000;49:896-903.
32. Lee JM, Seo WY, Song KH. AMPK-dependent repression of hepatic gluconeogenesis via disruption of CREB CRTC2 complex by orphan nuclear receptor small heterodimer partner. J. Biol. Chem. 2010;285:32182-32191.
33. Barthel A, Schmoll D. Novel concepts in insulin regulation of hepatic gluconeogenesis. Am. J. Physiol. Endocrinol. Metab. 2003;285:E685-E692.
34. Asai A, Chou PM, Bu HF. Dissociation of hepatic insulin resistance from susceptibility of nonalcoholic fatty liver disease induced by a high-fat and high-carbohydrate diet in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 2014;306:G496-G504.
35. Kotani K, Peroni OD, Minokoshi Y, et al. GLUT4 glucose transporter deficiency increases hepatic lipid production and peripheral lipid utilization. J. Clin. Invest. 2004;114:1666-1675.
36. Birkenfeld AL, Shulman GI. Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes. Hepatology. 2014;59:713-723.